Kapil Kumar has extensive experience in the pharmaceutical industry, currently serving as a Clinical Account Specialist and Field Sales Trainer at Alimera Sciences since November 2019, focusing on Iluvien. Prior roles include Hospital Sales Specialist at Roche Pharmaceuticals, Regional Account Manager at Vifor Fresenius Medical Care Renal Pharma, and Principal Key Account Manager at Novartis, where significant products promoted included Lucentis and several COPD medications. Kapil has a proven track record in launching products and obtaining formulary approvals across various healthcare institutions. Previous positions also include Key Account Manager at Eli Lilly and Company, Healthcare Development Manager, and Territory Business Manager at AstraZeneca. Kapil Kumar's educational background includes a BA(Hons) from West London Institute Of Higher Education.
This person is not in any offices
Alimera Sciences
1 followers
Alimera Sciences, Inc. (NASDAQ: ALIM) (“Alimera”), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Our lead product is ILUVIEN, now approved for marketing in the U...